Which of the following agents should not be used for oral anticoagulation in high risk patients with atrial fibrillation
Oral anticoagulation in high-risk patients with AF includes vitamin K antagonists or the newer anticoagulants such as thrombin inhibi- tors (dabigatran) or factor Xa inhibitors (rivaroxaban, apixaban), but not antiplatelet agents (aspirin and clopidogrel), which have substantially less effect. Ref Harrison 20th edition pg 1456
Wafarin
Dabigatran
Rivoraxaban
Clopidogrel
General anatomy